Enamel matrix derivative induces the expression of tissue inhibitor of matrix metalloproteinase-3 in human gingival fibroblasts via extracellular signal-regulated kinase

Journal of Periodontal Research

Volumn 45, Issue 2, 2010, Pages 200-206

  Zeldich, E ^a   Koren, R ^a   Dard, M ^b   Weinberg, E ^a   Weinreb, M ^a   Nemcovsky, C E ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b INSTITUT STRAUMANN AG   (Switzerland)

Author keywords

Enamel matrix derivative; Gingival fibroblast; Matrix metalloproteinase; Periodontal disease; Tissue inhibitor of matrix metalloproteinase

Indexed keywords

1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; AUTACOID; COLLAGENASE 3; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; ENZYME INHIBITOR; GELATINASE A; INTERSTITIAL COLLAGENASE; MATRILYSIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MMP1 PROTEIN, HUMAN; MMP13 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN; MMP3 PROTEIN, HUMAN; MMP7 PROTEIN, HUMAN; NITRILE; STROMELYSIN; TIMP3 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; FIBROBLAST; GINGIVA; HUMAN;

BUTADIENES; CELLS, CULTURED; DENTAL ENAMEL PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; FIBROBLASTS; GINGIVA; HUMANS; INFLAMMATION MEDIATORS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 7; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950199317     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2009.01218.x     Document Type: Article

References (56)

1. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999, 274:21491-21494.
2. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8:221-233.
3. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003, 200:448-464.
4. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001, 17:463-516.
5. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000, 1477:267-283.
6. Wojtowicz-Praga SM, Dickson RB, Hawkins MJ. Matrix metalloproteinase inhibitors. Invest New Drugs 1997, 15:61-75.
7. Trengove NJ, Stacey MC, MacAuley S. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999, 7:442-452.
8. Gill SE, Parks WC. Metalloproteinases and their inhibitors: regulators of would healing. Int J Biochem Cell Biol. 2008, 40:1334-1347.
9. Madianos PN, Bobetsis YA, Kinane DF. Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. J Clin Periodontol 2005, 32:57-71.
10. Graves DT, Cochran D. The contribution of IL-1 and TNF to periodontal tissue destruction. J Periodontol 2003, 74:391-401.
11. Reynolds JJ, Hembry RM, Meikle MC. Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res 1994, 8:312-319.
12. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976, 34:235-249.
13. Tervahartiala T, Pirilä E, Ceponis A. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J Dent Res 2000, 79:1969-1977.
14. Zhou J, Windsor LJ. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases. J Periodontal Res 2006, 41:47-54.
15. Aiba T, Akeno N, Kawane T, Okamoto H, Horiuchi N. Matrix metalloproteinases-1 and -8 and TIMP-1 mRNA levels in normal and diseased human gingiva. Eur J Oral Sci 1996, 104:562-569.
16. Soell M, Elkaim R, Tenenbaum H. Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients. J Dent Res 2002, 81:174-178.
17. Kim DM, Ramoni MF, Nevins M, Fiorellini JP. The gene expression profile in refractory periodontitis patients. J Periodontol 2006, 77:1043-1050.
18. Dahan M, Nawrocki B, Elkaïm R. Expression of MMPs in healthy and diseased human gingiva. J Clin Periodontol 2001, 28:128-136.
19. Kubota T, Itagaki M, Hoshino C. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue. J Periodontol 2008, 79:166-173.
20. Meikle MC, Atkinson SJ, Ward RV, Murphy G, Reynolds JJ. Gingival fibroblasts degrade type I collagen films when stimulated with TNF and IL-1: evidence that breakdown is mediated by metalloproteinases. J Periodontal Res 1989, 24:207-213.
21. Domeij H, Yucel-Lindberg T, Modeer T. Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur J Oral Sci 2002, 110:302-306.
22. Beklen A, Ainola M, Hukkanen M, Gürgan C, Sorsa T, Konttinen YT. MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res 2007, 86:347-351.
23. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Ann Periodontol 2003, 8:12-37.
24. Nemcovsky CE, Artzi Z, Tal H, Kozlovsky A, Moses O. A multicenter comparative study of 2 root coverage procedures: coronally advanced flap with the addition of enamel matrix proteins and subpedicle connective tissue graft. J Periodontol 2004, 75:608-615.
25. Cueva MA, Boltchi FE, Halmon WW, Nunn ME, Rivera-Hidalgo F, Rees T. A comparative study of coronally advanced flaps with and without the addition of enamel matrix derivative in the treatment of marginal tissue recession. J Periodontol 2004, 75:949-956.
26. Hägewald S, Spahr A, Rompola E, Haller B, Heijl L, Bernimoulin J-P. Comparative study of Emdogain and coronally advanced flap technique in the treatment of human gingival recessions. A prospective controlled clinical study. J Clin Periodontol 2002, 29:35-41.
27. Tonetti MS, Fourmousis I, Suvan J, Cortellini P, Bragger U, Lang NP. Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects. J Clin Periodontol 2004, 31:1092-1098.
28. Keila S, Nemcovsky CE, Moses O, Artzi Z, Weinreb M. In vitro effect of enamel matrix proteins on rat bone marrow cells and gingival fibroblasts. J Dent Res 2004, 83:134-138.
29. Zeldich E, Koren R, Nemcovsky C, Weinreb M. Enamel matrix derivative stimulates human gingival fibroblast proliferation via ERK. J Dent Res 2007, 86:41-46.
30. Zeldich E, Koren R, Dard M, Nemcovsky C, Weinreb M. Enamel matrix derivative protects human gingival fibroblast from TNF-induced apoptosis by inhibiting caspase activation. J Cell Physiol 2007, 213:750-758.
31. Okuda K, Miyazaki A, Momose M. Levels of tissue inhibitor of metalloproteinases-1 and matrix metalloproteinases-1 and -8 in gingival crevicular fluid following treatment with enamel matrix derivative (EMDOGAIN). J Periodontal Res 2001, 36:309-316.
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitive PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
33. Cury PR, Araújo VC, Canavez F, Furuse C, Araújo NS. Hydrocortisone affects the expression of matrix metalloproteinases (MMP-1, -2, -3, -7, and -11) and tissue inhibitor of matrix metalloproteinases (TIMP-1) in human gingival fibroblasts. J Periodontol 2007, 78:1309-1315.
34. Cury PR, Canavez F, de Araújo VC, Furuse C, de Araújo NS. Substance P regulates the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in cultured human gingival fibroblasts. J Periodontal Res 2008, 43:255-260.
35. Zhou J, Olson BL, Windsor LJ. Nicotine increases the collagen-degrading ability of human gingival fibroblasts. J Periodontal Res 2007, 42:228-235.
36. Kato T, Okahashi N, Ohno T, Inaba H, Kawai S, Amano A. Effect of phenytoin on collagen accumulation by human gingival fibroblasts exposed to TNF-alpha in vitro. Oral Dis 2006, 12:156-162.
37. Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004, 10:311-318.
38. Séguier S, Gogly B, Bodineau A, Godeau G, Brousse N. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue? J Periodontol 2001, 72:1398-1406.
39. Lee J, Jung E, Lee J. Emodin inhibits TNF alpha-induced MMP-1 expression through suppression of activator protein-1 (AP-1). Life Sci 2006, 79:2480-2485.
40. Dasu MR, Barrow RE, Spies M, Herndon DN. Matrix metalloproteinase expression in cytokine stimulated human dermal fibroblasts. Burns 2003, 29:527-531.
41. Wisithphrom K, Winsdor LJ. The effects of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and transforming growth factor-beta1 on pulp fibroblast mediated collagen degradation. J Endod 2006, 32:853-861.
42. O'Kane CM, Elkington PT, Friedland JS. Monocyte-dependent oncostatin M and TNF-alpha synergize to stimulate unopposed matrix metalloproteinase-1/3 secretion from human lung fibroblasts in tuberculosis. Eur J Immunol 2008, 38:1321-1330.
43. Tagoe CE, Marjanovic N, Park JY. Annexin-1 mediates TNF-alpha-stimulated matrix metalloproteinase secretion from rheumatoid arthritis synovial fibroblasts. J Immunol 2008, 181:2813-2820.
44. Kida Y, Kobayashi M, Suzuki T. Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts. Cytokine 2005, 29:159-168.
45. Wennström JL, Lindhe J. Some effects of enamel matrix proteins on wound healing in the dento-gingival region. J Clin Periodontol 2002, 29:9-14.
46. Zeldich E, Koren R, Dard M, Nemcovsky C, Weinreb M. The role of EGFR in EMD-induced gingival fibroblast mitogenesis. J Dent Res 2008, 87:850-855.
47. Zappa U, Boretti G, Graf H, Case D. Numbers and vitality of leukocytes in pocket washings of untreated periodontitis lesions in humans utilizing a novel intracrevicular lavage technique. J Periodontal Res 1992, 27:274-284.
48. Nemeth E, Kulkarni GW, McCulloch CA. Disturbances of gingival fibroblast population homeostasis due to experimentally induced inflammation in the cynomolgus monkey (Macaca fascicularis): potential mechanism of disease progression. J Periodontal Res 1993, 28:180-190.
49. Tonetti MS, Cortellini D, Lang NP. In situ detection of apoptosis at sites of chronic bacterially induced inflammation in human gingiva. Infect Immun 1998, 66:5190-5195.
50. Myhre AE, Lyngstadaas SP, Dahle MK. Anti-inflammatory properties of enamel matrix derivative in human blood. J Periodontal Res 2006, 41:208-213.
51. Sato S, Kitagawa M, Sakamoto K. Enamel matrix derivative exhibits anti-inflammatory properties in monocytes. J Periodontol 2008, 79:535-540.
52. Walter C, Jawor P, Bernimoulin JP, Hägewald S. Moderate effect of enamel matrix derivative (Emdogain Gel) on Porphyromonas gingivalis growth in vitro. Arch Oral Biol 2006, 51:171-176.
53. Spars A, Lyngstadaas SP, Boeckh C, Andersson C, Podbielski A, Haller B. Effect of the enamel matrix derivative Emdogain on the growth of periodontal pathogens in vitro. J Clin Periodontol 2002, 29:62-72.
54. Mizutani S, Tsuboi T, Tazoe M, Koshihara Y, Goto S, Togari A. Involvement of FGF-2 in the action of Emdogain on normal human osteoblastic activity. Oral Dis 2003, 9:210-217.
55. Laaksonen M, Suojanen J, Nurmenniemi S, Läärä E, Sorsa T, Salo T. The enamel matrix derivative (Emdogain) enhances human tongue carcinoma cells gelatinase production, migration and metastasis formation. Oral Oncol 2008, 44:733-742.
56. Qureshi HY, Sylvester J, El Mabrouk M, Zafarullah M. TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor. J Cell Physiol 2005, 203:345-352.